Evidence map›Paper›PMID 30382555›Full record

ReviewBiophysical reviews2018

S100 proteins as therapeutic targets.

Anne R Bresnick

Open access · greenAbstract readReview
In one paragraph

Review in Biophysical reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Virtual Probing on the Influence of CaCell biochemistry and biophysics · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anne R BresnickDepartment of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. anne.bresnick@einstein.yu.edu.ORCID http://orcid.org/0000-0003-1674-4568
Albert Einstein College of Medicine · US

Funding

Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
Regulation of the Class IA PI 3-kinase PIK3CBR01GM112524 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BACKER, JONATHAN M., BRESNICK, ANNE R · 2014 to 2017
$1.6M
The Role of PI3K Beta in Breast Cancer MetastasisR01GM119279 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BACKER, JONATHAN M., BRESNICK, ANNE R · 2016 to 2019
$1.5M
National Institutes of Health P01 CA100324National Institutes of Health R01 GM119279NCI NIH HHS P01 CA100324NIGMS NIH HHS R01 GM112524NIGMS NIH HHS R01 GM119279
6 · The paper itself

Abstract

The human genome codes for 21 S100 protein family members, which exhibit cell- and tissue-specific expression patterns. Despite sharing a high degree of sequence and structural similarity, the S100 proteins bind a diverse range of protein targets and contribute to a broad array of intracellular and extracellular functions. Consequently, the S100 proteins regulate multiple cellular processes such as proliferation, migration and/or invasion, and differentiation, and play important roles in a variety of cancers, autoimmune diseases, and chronic inflammatory disorders. This review focuses on the development of S100 neutralizing antibodies and small molecule inhibitors and their potential therapeutic use in controlling disease progression and severity.

Indexed as

Calcium bindingNeutralizing antibodyS100 proteinSmall molecule inhibitor

Identifiers

PMID30382555
PMCPMC6297089
OpenAlexW2899483281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.